UPL Ltd.’s profit for the quarter ended March missed estimates due to an exceptional loss which includes cost related to acquisition of Arysta Lifesciences Ltd. and a foreign exchange loss.
Add us to your Preferences
Set as your preferred source on Google
ADVERTISEMENT